FractureGlobal POISENCT05361980
Pediatric Orthopaedic Implant Safety & Efficacy
An observational study of Fracture and Lengthening; Leg, run by University of British Columbia at 1 site in Canada.
Trial summary
Implant devices are important tools - their use is essential across a number of orthopaedic indications, including hip conditions, trauma and limb deformity. Given the vital role fixation devices play in maintaining alignment, promoting healthy bone healing and preventing joint degeneration, it is essential to… Read more about this study
- Who is it for?
- Ages 0 to 25 yearsHealthy volunteers can take part
- Conditions the study is for
- Fracture, Lengthening; Leg, Orthopedic Disorder
- What is being tested?
- Pediatric orthopaedic implant
- Type of treatment
- Medical device
- How many people
- 4,000 participants
- Where
- 1 siteCanada
- Study dates
- 6 Jan 2022to Dec 2029
- How long will I take part?
- 2 Years
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 0 to 25 years
- All sexes
- Healthy volunteers accepted
- Child, Adult
Study population: Anyone who meets the eligibility criteria and is within the age limits listed in the above sections can participate in this study.
Who may be able to join
- Patients indicated for the device-specific indication, per physician discretion and as indicated in the device IFU. Off-label use is strongly discouraged; however, any and all on- and off-label indications for use of the products in this program will be collected and stratified accordingly
- Patients must be able to adhere to the required length of follow-up for the endpoints of each individual product
- Informed consent/assent is required
Who cannot join
- Patients with a demonstrated sensitivity to metals
- Patients with an inability to follow a post-operative regimen
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Canada1 site, 1 recruiting
- Recruiting
BC Children's Hospital
Vancouver, British Columbia, V6H 3N1
Emily Schaeffer, PhD, 604-875-2359, emily.schaeffer@cw.bc.ca
Anthony Cooper, FRCSC
About this study
Official title: Global Pediatric Orthopaedic Implant Safety & Efficacy Clinical Follow-up Program
Implant devices are important tools - their use is essential across a number of orthopaedic indications, including hip conditions, trauma and limb deformity.
Given the vital role fixation devices play in maintaining alignment, promoting healthy bone healing and preventing joint degeneration, it is essential to understand the expected lifetime outcomes of these implants, and evaluate their safety and efficacy.
Prospective implant efficacy and safety registries are needed to support this endeavour, especially considering new regulatory requirements from the European Union Medical Devices Regulation (EU MDR) in relation to post-market clinical follow-up (PMCF).
Read the detailed description
STUDY PROCEDURES Screening Patients will be screened against basic inclusion/exclusion criteria to see if patients may be appropriate for study participation according to any standard of care assessments available, and where appropriate with the site's REB/IRB screening procedures and local regulatory requirements. If a patient is deemed eligible, data outlined throughout this protocol will be collected, de-identified and entered into a Research Electronic Database Capture (REDCap) system managed at BCCH.
Enrollment Patients will be assigned a sequential, unique study number (subject ID) and de-identified data will be entered in the study database. The center number is designated by the BCCH team for each individual investigational site. The patient number will be in sequential order by the patient screening date starting with 001. Once a patient has been assigned a subject ID, the number will not be reused.
Pre-Operative Procedures Once a patient is identified as eligible for an Implant Safety and Efficacy device report, it will be determined whether that patient is already enrolled in one of the existing condition-specific registries. Should participants be enrolled in a condition-specific registry, demographic data, medical history, preoperative clinical data, including any pre-existing infections at or near the operative site, and data on pre-operative radiographs for the relevant underlying diagnosis will have already been prospectively collected under registry procedures. If a patient has not been previously enrolled in a condition-specific registry, the patient will be offered enrollment in both the condition registry and for the purposes of the Implant Safety and Efficacy device report. Demographic data, medical history, preoperative clinical data and data on pre-operative radiographs for the relevant underlying diagnosis will then be collected retrospectively from the medical record.
Required Data Collection:
Operative details in the source documentation will be collected that provide specific information from the subject's surgery such as surgical approach, complications, and unique device identification (UDI) numbers for the implanted device.
The following data will be collected and entered into the registry:
- Operative data, specific to the technique related to the relevant OrthoPediatrics system/device
- Assessments of any device-related adverse events
- Assessment for other adverse events
- When possible, the UDI number for the device(s) implanted, or information on the device implanted
Follow-up Procedures
Data collected during routine standard of care follow-up visits will be collected as part of this study. The following data will be collected:
- Radiographs obtained during study clinical evaluations to determine bony union, as well as healing or complications
- Device-related adverse events
- Unanticipated device-related serious adverse device effects
- Information on implant removals not related to an adverse event; degree of bony union just prior to implant removal Unscheduled Visits [if or when needed]
The condition-specific registries are designed to capture every visit that occurs, whether scheduled or unscheduled. An unscheduled visit may occur when an adverse event occurs, or when a patient returns outside of the planned interval window. If an unscheduled visit occurs, the following assessments are to be done:
- Assessment of any adverse events related to the device
- Survivorship of the device
- Conditions
- Fracture, Lengthening; Leg, Orthopedic Disorder, Deformity of Limb, Deformity; Bone, Implant Breakage
- Being tested
- Pediatric orthopaedic implant
- Medical subject headings
- Fractures, Bone, Musculoskeletal Diseases, Congenital Abnormalities, Hip Dislocation, Precursor Cell Lymphoblastic Leukemia-Lymphoma
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Pediatric orthopaedic implantDevice
Patient receives a pediatric orthopaedic implant as a part of standard clinical care.
| Study group | Role | What they receive |
|---|---|---|
| Longitudinal Observational Group | Pediatric patients indicated for the device-specific indication, per physician discretion and as indicated in the device IFU. Receives: Device: Pediatric orthopaedic implant |
What is being measured
The primary outcome is the main question the study is designed to answer.
Device related adverse events
Determine the frequency and severity of device-related adverse events at device-specific end points. All adverse events will be recorded and followed during the study. The frequency and severity of device related adverse events will be analyzed to ensure the device risk profile has not changed.
Measured: 2 years post implant insertion
Implant survival
Determine the implant survival rate at post-operative end-point: (lack of revision)
Measured: 2 years post implant insertion
Implant efficacy
Efficacy will be assessed by post-operative clinical and radiographic evaluations at each follow-up end-point to assess bone fixation and/or deformity correction.
Measured: 2 years post implant insertion
Secondary outcomes (3)
Numeric pain rating scale (NPRS)
The numeric pain rating scale (NPRS) is a subjective, 11-point numerical scale in which respondents self-report their pain on a scale of 0 (no pain at all) to 10 (worst pain imaginable).
Measured: 2 years post implant insertion
LIMB-Q Kids
LIMB-Q Kids is a new patient reported outcome measure (PROM) for children with lower limb deformities.
Measured: 2 years post implant insertion
PROMIS
The Patient Reported Outcomes Measurement Information System (PROMIS) measures are self-reported and parent-reported. It includes over 300 measures of global, physical, mental, and social health for adults and children in the general population and those living with a chronic condition. Specifically, the PROMIS Global Health will be administered to all patients while the PROMIS Physical Function - Mobility short form will be administered to those with an implant used in a lower extremity and the PROMIS Physical Function - Upper Extremity short form will be administered to those with an implant used in an upper extremity.
Measured: 2 years post implant insertion
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 May 2022
- Study start6 Jan 2022
- Primary completionDec 2028 (estimated)
- Study completionDec 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for FractureStudies of the same condition, open and under way.
- More trials run by University of British ColumbiaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 4,000 participants (estimated)
- Target duration
- 2 Years
Sponsor and investigators
- Lead sponsor
- University of British Columbia
- Sponsor type
- University, hospital or other
- Collaborators
- OrthoPediatrics
- Responsible party
- Principal investigator, Kishore Mulpuri, University of British Columbia
- Investigators
- Bryn Zomar, PhD, Study director, University of British Columbia
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05361980
- Sponsor's protocol ID
- H21-03076
- Acronym
- Global POISE
- Status last verified
- Nov 2025
- First submitted
- 17 Dec 2021
- Last updated
- 24 Nov 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 24 Nov 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Global Pediatric Orthopaedic Implant Safety & Efficacy Clinical Follow-up Program
- ClinicalTrials.gov ID
- NCT05361980
- Acronym / sponsor ID
- Global POISE / H21-03076
- Conditions
- Fracture, Lengthening; Leg, Orthopedic Disorder, Deformity of Limb, Deformity; Bone, Implant Breakage
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 4,000 participants (estimated)
- Lead sponsor
- University of British ColumbiaUniversity, hospital or other
- Collaborators
- OrthoPediatrics
- Study start
- 6 Jan 2022 (actual)
- Primary completion
- Dec 2028 (estimated)
- Study completion
- Dec 2029 (estimated)
- First posted
- 5 May 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Implant devices are important tools - their use is essential across a number of orthopaedic indications, including hip conditions, trauma and limb deformity.
Given the vital role fixation devices play in maintaining alignment, promoting healthy bone healing and preventing joint degeneration, it is essential to understand the expected lifetime outcomes of these implants, and evaluate their safety and efficacy.
Prospective implant efficacy and safety registries are needed to support this endeavour, especially considering new regulatory requirements from the European Union Medical Devices Regulation (EU MDR) in relation to post-market clinical follow-up (PMCF).
Detailed description
STUDY PROCEDURES Screening Patients will be screened against basic inclusion/exclusion criteria to see if patients may be appropriate for study participation according to any standard of care assessments available, and where appropriate with the site's REB/IRB screening procedures and local regulatory requirements. If a patient is deemed eligible, data outlined throughout this protocol will be collected, de-identified and entered into a Research Electronic Database Capture (REDCap) system managed at BCCH.
Enrollment Patients will be assigned a sequential, unique study number (subject ID) and de-identified data will be entered in the study database. The center number is designated by the BCCH team for each individual investigational site. The patient number will be in sequential order by the patient screening date starting with 001. Once a patient has been assigned a subject ID, the number will not be reused.
Pre-Operative Procedures Once a patient is identified as eligible for an Implant Safety and Efficacy device report, it will be determined whether that patient is already enrolled in one of the existing condition-specific registries. Should participants be enrolled in a condition-specific registry, demographic data, medical history, preoperative clinical data, including any pre-existing infections at or near the operative site, and data on pre-operative radiographs for the relevant underlying diagnosis will have already been prospectively collected under registry procedures. If a patient has not been previously enrolled in a condition-specific registry, the patient will be offered enrollment in both the condition registry and for the purposes of the Implant Safety and Efficacy device report. Demographic data, medical history, preoperative clinical data and data on pre-operative radiographs for the relevant underlying diagnosis will then be collected retrospectively from the medical record.
Required Data Collection:
Operative details in the source documentation will be collected that provide specific information from the subject's surgery such as surgical approach, complications, and unique device identification (UDI) numbers for the implanted device.
The following data will be collected and entered into the registry:
- Operative data, specific to the technique related to the relevant OrthoPediatrics system/device
- Assessments of any device-related adverse events
- Assessment for other adverse events
- When possible, the UDI number for the device(s) implanted, or information on the device implanted
Follow-up Procedures
Data collected during routine standard of care follow-up visits will be collected as part of this study. The following data will be collected:
- Radiographs obtained during study clinical evaluations to determine bony union, as well as healing or complications
- Device-related adverse events
- Unanticipated device-related serious adverse device effects
- Information on implant removals not related to an adverse event; degree of bony union just prior to implant removal Unscheduled Visits [if or when needed]
The condition-specific registries are designed to capture every visit that occurs, whether scheduled or unscheduled. An unscheduled visit may occur when an adverse event occurs, or when a patient returns outside of the planned interval window. If an unscheduled visit occurs, the following assessments are to be done:
- Assessment of any adverse events related to the device
- Survivorship of the device
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 2 Years
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Longitudinal Observational Group | – | Device: Pediatric orthopaedic implantPediatric patients indicated for the device-specific indication, per physician discretion and as indicated in the device IFU. |
Who may qualify
- Ages
- 0 to 25 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult
- Study population
- Anyone who meets the eligibility criteria and is within the age limits listed in the above sections can participate in this study.
Key inclusion criteria (3 listed)
- Patients indicated for the device-specific indication, per physician discretion and as indicated in the device IFU. Off-label use is strongly discouraged; however, any and all on- and off-label indications for use of the products in this program will be collected and stratified accordingly
- Patients must be able to adhere to the required length of follow-up for the endpoints of each individual product
- Informed consent/assent is required
Key exclusion criteria (2 listed)
- Patients with a demonstrated sensitivity to metals
- Patients with an inability to follow a post-operative regimen
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Pediatric orthopaedic implantPatient receives a pediatric orthopaedic implant as a part of standard clinical care. | Device | Longitudinal Observational Group |
Primary outcome
Device related adverse events
Time frame: 2 years post implant insertion
Determine the frequency and severity of device-related adverse events at device-specific end points. All adverse events will be recorded and followed during the study. The frequency and severity of device related adverse events will be analyzed to ensure the device risk profile has not changed.
Implant survival
Time frame: 2 years post implant insertion
Determine the implant survival rate at post-operative end-point: (lack of revision)
Implant efficacy
Time frame: 2 years post implant insertion
Efficacy will be assessed by post-operative clinical and radiographic evaluations at each follow-up end-point to assess bone fixation and/or deformity correction.
3 secondary outcomes
Numeric pain rating scale (NPRS)
Time frame: 2 years post implant insertion
LIMB-Q Kids
Time frame: 2 years post implant insertion
PROMIS
Time frame: 2 years post implant insertion
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Nov 2025.
- Individual participant dataSharing planned: No
Related trials for Fracture
Not yet recruiting
Biodegradable Magnesium Screws for Unstable Ankle Fracture Surgery
Ankle Fractures, Syndesmotic Injury
Active, not recruitingObservational study
The Developmental Origins of Suicide Mortality
Suicide Mortality
RecruitingObservational study
Duration of Immobilization After Reverse Total Arthroplasty for Proximal Humerus Fractures
Proximal Humeral Fracture, Reverse Total Shoulder Arthroplasty
Recruiting
No Reduction Compared to Closed Reduction for Distal Radius Fractures in Patients Over 65 or Older
Distal Radius Fracture, Casting
RecruitingObservational study
A Clinical Study to Collect Real-wordt Data on Safety and Clinical Performance of the VCFix Spinal System for Treatment of Vertebral Compression Fractures of (Suspected) Osteoporotic Origin.
Vertebra Compression Fracture
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Bryn Zomar, PhD study director
University of British Columbia
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Fracture and Lengthening; Leg, run by University of British Columbia at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 24 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Bryn Zomar, PhD (604-875-2359, bryn.zomar@cw.bc.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Device related adverse events (time frame: 2 years post implant insertion). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Nov 2025.